SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (670)1/21/2005 2:30:32 PM
From: Jibacoa  Respond to of 3722
 
ARIA Started the day with good up volume in the first half hour, but found resistance at the $7.24 level.(A penny below its intraday H of $7.25 on Jan.7 )

The stock needs to close above its Jan.4 H of $7.33 before it can test its Dec.23 H at $7.63 <g> If it can do that then it still has to deal with its Jun.8 H at $9.14 (Jun.7 was when it dipped from $10.70 to $8.94 on volume of 4.222M )

The stock is still up 10% and volume above 2M

bigcharts.marketwatch.com

In Nov. it received a "buy" recommendation from AG Edwards and in Dec. from Sun Trust.<g>

Maybe the stock can get to trade at the $10 level sometime this year.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (670)1/22/2005 12:26:14 AM
From: Mike McFarland  Respond to of 3722
 
Nice summary--looks like a third of the
volume in GLGC today went off at the low.
4th Quarter report should be out anytime
now. I'd like to think that while all this
stem cell nonsense has been going on, they've
been productive. I'm down 8% in my position--
two weeks ago the CEO could have belched
and the shares would have gone up 30%.
Eight percent is nothing, I'll try not to
whine again, thanks again for your spending
some time looking at this one. I think it
is not a bad speculation--if they ever
get around to pressing Wall Street's buttons
again, it should do well, general market
conditons notwithstanding.